(Q41517445)

2 October 2017

1 reference

title

When, and when not, to use digoxin in the elderly (English)

1 reference

2 October 2017

0 references

Harry J. G. M. Crijns

series ordinal

3

object named as

Crijns HJ

1 reference

2 October 2017

Gosselink AT

1

1 reference

2 October 2017

van Veldhuisen DJ

series ordinal

2

1 reference

2 October 2017

publication date

1 June 1997

1 reference

2 October 2017

1 reference

2 October 2017

volume

10

1 reference

2 October 2017

issue

6

1 reference

2 October 2017

page(s)

411-420

1 reference

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

2 October 2017

cites work

1 reference

12 December 2020

Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Digoxin. A neurohormonal modulator in heart failure?

1 reference

12 December 2020

Value of digoxin in heart failure and sinus rhythm: new features of an old drug?

1 reference

12 December 2020

Diastolic dysfunction in elderly patients with congestive heart failure

1 reference

12 December 2020

Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent

1 reference

12 December 2020

Potential deleterious effects of inotropic agents in the therapy of chronic heart failure

1 reference

12 December 2020

Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial

1 reference

12 December 2020

Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?

1 reference

12 December 2020

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

12 December 2020

Digitalis-associated cardiac mortality after myocardial infarction

1 reference

12 December 2020

Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation

1 reference

12 December 2020

A comparison of verapamil and digoxin in the treatment of atrial fibrillation

1 reference

12 December 2020

Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

1 reference

12 December 2020

Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.

1 reference

12 December 2020

Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group

1 reference

12 December 2020

Functional capacity before and after cardioversion of atrial fibrillation: a controlled study

1 reference

12 December 2020

Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study.

1 reference

12 December 2020

Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation

1 reference

12 December 2020

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

1 reference

12 December 2020

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin

1 reference

12 December 2020

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group

1 reference

12 December 2020

To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis

1 reference

12 December 2020

Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure

1 reference

12 December 2020

Digitalis and neurohormonal abnormalities in heart failure and implications for therapy

1 reference

12 December 2020

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

12 December 2020

Digoxin for atrial fibrillation: a drug whose time has gone?

1 reference

12 December 2020

Changes in cardiovascular function with aging

1 reference

12 December 2020

Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease

1 reference

12 December 2020

Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group

1 reference

12 December 2020

Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation

1 reference

12 December 2020

Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing?

1 reference

12 December 2020

Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Atrial fibrillation: maintenance of sinus rhythm versus rate control

1 reference

12 December 2020

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

1 reference

12 December 2020

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin

1 reference

12 December 2020

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

12 December 2020

Digoxin in eurhythmic heart failure: PROVED or "not proven"?

1 reference

12 December 2020

Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation

1 reference

12 December 2020

Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil

1 reference

12 December 2020

Digitalis. Mechanisms of action and clinical use.

1 reference

12 December 2020

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

12 December 2020

Alteration of peripheral vasodilatory reserve capacity after cardioversion of atrial fibrillation

1 reference

12 December 2020

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

12 December 2020

Digitalis and the autonomic nervous system

1 reference

12 December 2020

Pharmacokinetic interactions between digoxin and other drugs

1 reference

12 December 2020

Clinical use of serum digoxin concentrations

1 reference

12 December 2020

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state

1 reference

12 December 2020

10.2165/00002512-199710060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 October 2017

1046493587

0 references

1 reference